drugset / Trial / NCT03281382
Phase 1 Trial of Interleukin 12 Gene Therapy for Metastatic Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
This phase 1 trial will investigate the toxicity of combining interleukin 12 gene therapy with standard chemotherapy in metastatic pancreatic cancer.
Timeline
- Start
- 2017-07-01
- Primary completion
- 2019-05-28
- Completion
- 2019-05-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ad5-yCD/mutTKSR39rep-hIL12 | Unknown | 1e+11 unknown | Other |
| Subject | Ad5-yCD/mutTKSR39rep-hIL12 | Unknown | 3e+11 unknown | Other |
| Subject | Ad5-yCD/mutTKSR39rep-hIL12 | Unknown | 1e+12 unknown | Other |